Abstract A035-PR003: EWS::FLI1 Expression in Human Embryonic Mesenchymal Stem Cells Leads to Transcriptional Reprograming, Defective DNA Damage Repair and Ewing Sarcoma

Abstract Ewing sarcoma (ES) is an aggressive bone and soft tissue neoplasm characterized by EWSR::ETS rearrangements whose cellular origin remains unclear. EWS::FLI1 expression in human pediatric mesenchymal stem cells (MSCs) induces a transcriptional response distinct from that of human adult MSCs, but fails to form tumors. We have generated MSCs from experimental teratomas out of human embryonic stem cells. EWS::FLI1 expression in these human embryonic mesenchymal stem cells (heMSCs) results in the acquisition of an ES transcriptome, with the oncogene not preferentially binding to promoters, but to intronic -with >10 CA dinucleotides- and intergenic microsatellites with GGAA repeats. In heMSCs, EWS::FLI1 directly regulates BRCA1 expression, even though EWS::FLI1-expressing cells show defects in DNA damage repair. Xenografting of EWS::FLI1-transduced heMSCs resulted in the formation of tumors expressing characteristic ES markers. In summary, we show that EWS::FLI1 enforces an aberrant transcriptome and solely is able to endow transforming capacity when expressed in undifferentiated, early heMSCs. Citation Format: Inmaculada Hernandez, Irene cuervas, Estela prada, Angel Raya, Jaume Mora. EWS::FLI1 Expression in Human Embryonic Mesenchymal Stem Cells Leads to Transcriptional Reprograming, Defective DNA Damage Repair and Ewing Sarcoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Discovery and Innovation in Pediatric Cancer— From Biology to Breakthrough Therapies; 2025 Sep 25-28; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2025;85(18_Suppl_2):Abstract nr A035-PR003.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-09-25
DOI
https://doi.org/10.1158/1538-7445.pediatric25-a035-pr003
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract A035-PR003: EWS::FLI1 Expression in Human Embryonic Mesenchymal Stem Cells Leads to Transcriptional Reprograming, Defective DNA Damage Repair and Ewing Sarcoma

Inmaculada Hernández, Jaume Mora, Ángel Raya, Estela Prada et al.
Cancer Research
RNA modifications and cancer
article

Abstract A035-PR003: EWS::FLI1 Expression in Human Embryonic Mesenchymal Stem Cells Leads to Transcriptional Reprograming, Defective DNA Damage Repair and Ewing Sarcoma

Inmaculada Hernández, Jaume Mora, Ángel Raya, Estela Prada, Irene Cuervas
article en

Abstract

Abstract Ewing sarcoma (ES) is an aggressive bone and soft tissue neoplasm characterized by EWSR::ETS rearrangements whose cellular origin remains unclear. EWS::FLI1 expression in human pediatric mesenchymal stem cells (MSCs) induces a transcriptional response distinct from that of human adult MSCs, but fails to form tumors. We have generated MSCs from experimental teratomas out of human embryonic stem cells. EWS::FLI1 expression in these human embryonic mesenchymal stem cells (heMSCs) results in the acquisition of an ES transcriptome, with the oncogene not preferentially binding to promoters, but to intronic -with >10 CA dinucleotides- and intergenic microsatellites with GGAA repeats. In heMSCs, EWS::FLI1 directly regulates BRCA1 expression, even though EWS::FLI1-expressing cells show defects in DNA damage repair. Xenografting of EWS::FLI1-transduced heMSCs resulted in the formation of tumors expressing characteristic ES markers. In summary, we show that EWS::FLI1 enforces an aberrant transcriptome and solely is able to endow transforming capacity when expressed in undifferentiated, early heMSCs. Citation Format: Inmaculada Hernandez, Irene cuervas, Estela prada, Angel Raya, Jaume Mora. EWS::FLI1 Expression in Human Embryonic Mesenchymal Stem Cells Leads to Transcriptional Reprograming, Defective DNA Damage Repair and Ewing Sarcoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Discovery and Innovation in Pediatric Cancer— From Biology to Breakthrough Therapies; 2025 Sep 25-28; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2025;85(18_Suppl_2):Abstract nr A035-PR003.

Cancer ResearchVol. 85(18_Supplement_2)
Barcelona Media (ES)
Openalex Percentile: Top 77%
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Abstract A035-PR003: EWS::FLI1 Expression in Human Embryonic Mesenchymal Stem Cells Leads to Transcriptional Reprograming, Defective DNA Damage Repair and Ewing Sarcoma — Inmaculada Hernández, Jaume Mora, et al. · Cancer Research (2025) | TGRS Research Map | TGRS